Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology
- PMID: 35536415
- DOI: 10.1007/s00247-022-05374-y
Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology
Abstract
Phosphate has extensive physiological roles including energy metabolism, genetic function, signal transduction and membrane integrity. Regarding the skeleton, not only do phosphate and calcium form the mineral component of the skeleton, but phosphate is also essential in regulating function of skeletal cells. Although our understanding of phosphate homeostasis has lagged behind and remains less than that for calcium, considerable advances have been made since the recognition of fibroblast growth factor-23 (FGF23) as a bone-derived phosphaturic hormone that is a major regulator of phosphate homeostasis. In this two-part review of disorders of phosphate homeostasis in children, part 1 covers the basics of mineral ion homeostasis and the roles of phosphate in skeletal biology. Part 1 includes phosphate-related disorders of mineralization for which overall circulating mineral ion homeostasis remains normal. Part 2 covers hypophosphatemic and hyperphosphatemic disorders, emphasizing, but not limited to, those related to increased and decreased FGF23 signaling, respectively.
Keywords: Bone; Children; Fibroblast growth factor-23; Generalized arterial calcification of infancy; Hypophosphatasia; Mineralization; Phosphate; Radiography.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.Pediatr Radiol. 2022 Nov;52(12):2290-2305. doi: 10.1007/s00247-022-05373-z. Epub 2022 May 10. Pediatr Radiol. 2022. PMID: 35536416 Review.
-
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.Curr Opin Nephrol Hypertens. 2007 Jul;16(4):329-35. doi: 10.1097/MNH.0b013e3281ca6ffd. Curr Opin Nephrol Hypertens. 2007. PMID: 17565275 Review.
-
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization.Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E1-9. doi: 10.1152/ajpendo.00016.2003. Am J Physiol Endocrinol Metab. 2003. PMID: 12791601 Review.
-
Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.J Bone Miner Res. 2017 Oct;32(10):2049-2061. doi: 10.1002/jbmr.3195. Epub 2017 Jul 17. J Bone Miner Res. 2017. PMID: 28600880
-
The skeleton: endocrine regulator of phosphate homeostasis.Curr Osteoporos Rep. 2008 Dec;6(4):134-41. doi: 10.1007/s11914-008-0024-6. Curr Osteoporos Rep. 2008. PMID: 19032923 Review.
Cited by
-
Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy.Front Pediatr. 2023 Apr 12;11:1129156. doi: 10.3389/fped.2023.1129156. eCollection 2023. Front Pediatr. 2023. PMID: 37124175 Free PMC article.
References
-
- Christov M, Jüppner H (2018) Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab 32:685–706 - PubMed
-
- Kinoshita Y, Fukumoto S (2018) X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases: prospect for new treatment. Endocr Rev 39:274–291 - PubMed
-
- Bitzan M, Goodyer PR (2019) Hypophosphatemic rickets. Pediatr Clin N Am 66:179–207
-
- Meyer RA, Meyer MH, Gray RW (1989) Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J Bone Miner Res 4:493–500 - PubMed
-
- Levine BS, Kleeman CR, Felsenfeld AJ (2009) The journey from vitamin D-resistant rickets to the regulation of renal phosphate transport. Clin J Am Soc Nephrol 4:1866–1877 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources